Generic Name and Formulations:
Hydrocodone bitartrate, ibuprofen; 2.5mg/200mg, 5mg/200mg, 10mg/200mg; tabs.
Indications for REPREXAIN:
Short term (generally <10 days) management of acute pain.
Individualize; use lowest effective dose for shortest duration. ≥16yrs: 1 tab every 4–6 hours as needed; max 5 tabs/day.
<16yrs: not recommended.
Aspirin allergy. Coronary artery bypass graft surgery.
NSAIDs may increase risk of cardiovascular thrombotic events, MI, stroke; may be fatal. Advanced renal disease: not recommended. Head injury. Increased intracranial pressure. Acute abdomen. Peptic ulcer. History of upper GI disease/bleed. Impaired renal, hepatic, thyroid, pulmonary, or adrenocortical function. GI or GU obstruction. Asthma. Edema. Hypertension. Heart failure. Coagulation disorders. Monitor BP; hepatic, and renal function (long-term use). Post-op (may suppress cough reflex). Drug abusers. Discontinue if hepatic dysfunction occurs. Elderly. Debilitated. Pregnancy (Cat.C; avoid in 3rd trimester). Labor & delivery, nursing mothers: not recommended.
Avoid aspirin. Additive CNS depression with alcohol, antihistamines, antipsychotics, antianxiety agents, other CNS depressants; reduce dose of either or both drugs if used together. May potentiate, or be potentiated by, MAOIs or tricyclic antidepressants. May increase bleeding with corticosteroids, anticoagulants, smoking, alcohol, long-term NSAID use. Hydrocodone may potentiate skeletal muscle relaxants. May reduce efficacy of, and increase risk of renal failure with, ACEIs, diuretics. Paralytic ileus may occur with anticholinergics. May increase lithium, methotrexate toxicity. Caution with pentazocine, nalbuphine, butorphanol, buprenorphine.
Opioid + NSAID.
Headache, somnolence, dizziness, GI upset/bleed, constipation, edema, rash (discontinue if occurs), anaphylaxis; anemia, respiratory depression, aseptic meningitis (rare); others. See literature re: risk of cardiovascular events.
Renal and Urology News Articles
- Daily Tadalafil May Be Effective for Peyronie's Disease
- High ESA and Iron Doses Up CVD, Death Risk in Hemodialysis Patients
- Diabetic CKD Patients Survive Longer With Metformin
- Tamsulosin Improves Clearance of Large Distal Ureteral Stones
- Case: Treating Iron Deficiency Anemia in a Heart Failure Patient
- Cytoreductive Nephrectomy Benefits for Metastatic RCC Demonstrated
- Phosphorus Content Higher in Packaged Meats Listing Phosphate Additives
- High Intakes of Teas, Peas, Soybeans May Increase Prostate Cancer Risk
- More Intense Treatment, Worse Quality of Life in Diabetes
- Hemodialysis CRBSI Outcomes Unaffected by Distance to Nephrologists
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)